Antituberculosis drug resistance patterns in adults with tuberculous meningitis: results of haydarpasa-iv study
Yazar
Kursun, Ebru
Sunbul, Mustafa
Alabay, Selma
BEOVIC, Bojana
Ulu-Kilic, Aysegul
CATROUX, Melanie
INAN, Asuman
DRAGOVAC, Gorana
Deveci, Ozcan
Tekin, Recep
GUL, Hanefi Cem
SENGOZ, Gonul
ANDRE, Katell
HARXHI, Arjan
HANSMANN, Yves
Oncu, Serkan
KOSE, Sukran
Parlak, Emine
Sener, Alper
Yilmaz, Gulden
CAG, Yasemin
Yemisen, Mücahit
ERDEM, Hakan
ONCUL, Oral
SAVASCI, Umit
VAHABOGLU, Haluk
SENBAYRAK, Seniha
Ozkutuk, Nuri
JOHANSEN, Isik Somuncu
CIVLJAK, Rok
İNAL, AYŞE SEZA
Kayabas, Uner
ELALDI, NAZİF
SAVIC, Branislava
SIMEON, Soline
Yilmaz, Emel
DULOVIC, Olga
OZTURK-ENGIN, Derya
CERAN, Nurgul
LAKATOS, Botond
Sipahi, Oguz Resat
Üst veri
Tüm öğe kaydını gösterÖzet
Background: Tuberculous meningitis (TBM) caused by Mycobacterium tuberculosis resistant to antituberculosis drugs is an increasingly common clinical problem. This study aimed to evaluate drug resistance profiles of TBM isolates in adult patients in nine European countries involving 32 centers to provide insight into the empiric treatment of TBM.
Koleksiyonlar
- Makale [92796]